| Completed | A Study to Compare Bioavailability of Naloxone Nasal Spray, Naloxone Hydrochloride (HCl) Intravenous (IV) and Healthy Volunteer | Phase 1 | 2018-04-23 |
| Withdrawn | Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome | Phase 3 | 2017-12-30 |
| Withdrawn | Fentanyl Sublingual Spray for the Treatment of Acute Procedure-related Pain in a Monitored Setting Chronic Pain | Phase 3 | 2017-12-30 |
| Withdrawn | Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome | Phase 3 | 2017-12-30 |
| Completed | Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Ope Pain, Postoperative | Phase 2 | 2017-09-12 |
| Completed | A Study to Compare Bioavailability of Naloxone Nasal Spray and Naloxone Hydrochloride (HCl) Intramuscular Inje Healthy Volunteer | Phase 1 | 2017-08-07 |
| Completed | Fentanyl Sublingual Spray for the Treatment of Moderate to Severe Post-Operative Pain Pain | Phase 2 | 2016-12-01 |
| Completed | Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain Pain | Phase 3 | 2016-01-29 |
| Terminated | Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms Spasms, Infantile | Phase 2 | 2016-01-27 |
| Completed | Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder Seizures | Phase 3 | 2016-01-08 |
| Completed | Fentanyl Sublingual Spray in Opioid Naive Participants Pharmacology | Phase 1 | 2016-01-01 |
| Completed | Comparative Bioavailability of Dronabinol Oral Solution in Healthy Volunteers Healthy | N/A | 2015-11-01 |
| Completed | Fentanyl Sublingual Spray and Fentanyl Citrate Intravenous (IV) in Opioid Naive Subjects Pharmacokinetics and Pharmacodynamics | Phase 1 | 2015-10-01 |
| Completed | Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers Opiate Dependence | Phase 1 | 2015-06-01 |
| Completed | Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders Seizures | Phase 1 / Phase 2 | 2015-04-13 |
| Terminated | Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain Post-operative Pain | Phase 3 | 2015-02-24 |
| Completed | A Study of the Abuse Potential of Dronabinol in Recreational Cannabinoid Users Drug Abuse, Medication | Phase 1 | 2014-02-01 |
| Completed | Exploratory Bioavailability of Fentanyl Sublingual Spray Under Fasting Conditions Bioavailability | N/A | 2014-01-01 |
| Terminated | Possible New Therapy for Advanced Cancer Adrenocortical Carcinoma | Phase 1 | 2012-12-01 |
| Completed | Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions Bioavailability | Phase 1 | 2011-10-01 |
| Withdrawn | Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate Cancer Prostate Cancer | Phase 2 | 2010-06-01 |
| Completed | Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2010-04-01 |
| Completed | Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral Mucositis Mucositis, Pain, Unspecified Adult Solid Tumor, Protocol Specific | Phase 3 | 2009-10-01 |
| Completed | Efficacy and Safety Study of LEP-ETU to Treat Metastatic Breast Cancer Breast Cancer | Phase 2 | 2008-03-01 |
| Completed | Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid Tumors Solid Tumors | Phase 1 | 2008-02-01 |
| Completed | Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain Cancer, Pain | Phase 3 | 2007-12-01 |
| Completed | Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Cancer | Phase 3 | 2007-10-01 |
| Completed | Pharmacokinetic Study of Fentanyl 400 µg Sublingual Spray, Actiq® 400 µg Transmucosally, and Fentanyl Citrate Pain | Phase 1 | 2007-04-01 |
| Completed | Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Cancer Neoplasms | Phase 1 | 2004-12-01 |
| Completed | Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Neoplasm | Phase 1 | 2004-11-01 |
| Completed | IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Pat Glioblastoma Multiforme, Anaplastic Astrocytoma, Oligoastrocytoma | Phase 1 | 2004-07-01 |
| Completed | The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Mul Glioblastoma Multiforme | Phase 3 | 2004-02-01 |
| Completed | Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer Neoplasm | Phase 1 | 2003-07-01 |
| Completed | Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recu Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma | Phase 1 | 2003-07-01 |
| Completed | Liposome Encapsulated SN38 (LE-SN38) in Patients With Advanced Cancer Neoplasms | Phase 1 | 2002-10-01 |
| Completed | Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma | Phase 1 / Phase 2 | 2002-07-01 |
| Completed | Study of Liposome Encapsulated Mitoxantrone (LEM) in Patients With Advanced Cancer Tumors | Phase 1 | 2001-08-01 |
| Completed | Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant G Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma | Phase 1 | 2001-06-01 |
| Completed | Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Mal Neoplasms | Phase 1 | 2001-03-01 |
| Completed | Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors Neoplasms | Phase 1 | 2001-03-01 |
| Withdrawn | Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 1 Neoplasms | Phase 1 | 2001-02-01 |
| Completed | Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma | Phase 1 / Phase 2 | 2000-11-01 |
| Withdrawn | Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Dos Neoplasms | Phase 1 | 2000-11-01 |
| Withdrawn | Study to Explore Effectiveness of Sublingual Fentanyl Spray in Emergency Department Patients With Acute Pain Acute Pain | Phase 2 | — |
| Withdrawn | Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma Recurrent Malignant Glioma | Phase 1 / Phase 2 | — |